Fibrin glue

PreclinicalSmall molecule

FFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Fibrin glue is one of 9 small molecule programs targeting Anal fistula. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Anal FistulaActive, not recruiting

Anal FistulaPreclinical

Active, not recruiting

Competition

Competitive Landscape

10 competitors in Anal Fistula

#DrugCompanyPhaseTrials

Humira

Novartis

Approved

2 2

Acanya

Marcaine

Dilantin

VViatris Specialty LLC

Preclinical

—5

Amoxil

GGlobal Antibiotics Research and Development Partnership

AVB-114

1 7

E-CEL UVEC

WWeill Medical College of Cornell University

Phase 1

1 8

Amoxicillin-Clavulanate

IIterum Therapeutics, International Limited

Preclinical

1 9

Fibrin glue

FFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Prevention2 trials

Postoperative Bleeding Prevention in Massive Bone Tumour Resection

Terminated·FFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau·Phase 3·NCT02153593·56 enrolled

Prevention of Postoperative Bleeding in Subcapital Femoral Fractures

Completed·FFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau·Phase 3·NCT02150720·161 enrolled

Injury1 trial

Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)

Completed·SSeoul National University Hospital·Phase 2·NCT03449082·30 enrolled

Anal fistula1 trial

Long-term Safety and Efficacy of Adipose-derived Stem Cells to Treat Complex Perianal Fistulas in Patients Participating in the FATT-1 Randomized Controlled Trial

Completed·TTigenix S.A.U.··NCT01020825·148 enrolled

Anastomotic Leak1 trial

Prevention of Anastomotic Leak in Gastrointestinal (GI) Anastomosis With the Application of Tisseal in the Anastomotic Line

Unknown status·HHospital General Universitario Gregorio Marañon·Phase 4·NCT01306851·200 enrolled

Kidney Transplant1 trial

Fibrin Based Adhesive for the Prevention of Surgical Complications in the Kidney Transplantation

Completed·AAlejandro Gonzalez-Ojeda·Phase 3·NCT01631448·152 enrolled

2 more indications

Efficacy and Safety1 trial

Clinical Trial to Evaluate the Efficacy and Safety of Stem Cells

Completed·IInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz·Phase 3·NCT01803347·80 enrolled

Total Knee Arthroplasty1 trial

Fibrin Glue or Tranexamic Acid for Total Knee Arthroplasty

Completed·FFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau·Phase 3·NCT01306370·172 enrolled

Sources

References

[1]
ClinicalTrials.gov — 8 trial records for Fibrin glue. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Fibrin glue compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Fibrin glue. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: FFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Fibrin glue

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Prevention2 trials

Injury1 trial

Anal fistula1 trial

Anastomotic Leak1 trial

Kidney Transplant1 trial

Efficacy and Safety1 trial

Total Knee Arthroplasty1 trial

References

Drug Info

Quick Facts

Related News